Home » Newsletters » BioWorld

BioWorld

July 27, 1999

View Archived Issues

Appointments And Advancements

Other News To Note

Maxim Raises $20M For Phase III Programs

FDA Declines To Approve Magainin's Antibiotic Drug

Neuron-Saving Ganglioside Drug Seeks 150 Parkinson Patients To Sign Up For Phase II Study

Targeted Genetics, Elan Team In Venture For Gene Delivery

NaPro, Abbott Partner In Deal Worth Up To $125M